Jadoul M, Lameire N, Bragg-Gresham J L, Eichleay M A, Pisoni R L, Port F K
Cliniques universitaire Saint Luc, Service de Néphrologie, 10, avenue Hippocrate, 1200 Bruxelles, Belgium.
Acta Clin Belg. 2007 Mar-Apr;62(2):102-10. doi: 10.1179/acb.2007.018.
Various organizations have published clinical practice guidelines for the care of haemodialysis patients. However, it is unknown to what extent improving or even reaching perfect compliance with guidelines would improve the survival of HD patients in Belgium.
Using data from the second phase of the Dialysis Outcomes and Practice Patterns Study (DOPPS), the proportion of haemodialysis patients failing to meet six key practice targets (Kt/V > or = 1.2, haemoglobin > or =11 g/dl, phosphate 1.1-1.5 mmol/l, calcium 2.1-2, 4 mmol/l, albumin > or =40 g/l, and facility catheter use < or =10%) was calculated along with the relative risk of mortality associated with being outside these targets. The life years potentially gained from adherence to the six targets, both separately and all six together were then estimated.
The percentage of patients outside the targets were as follows: 30.3%, Kt/V; 33.6%, haemoglobin; 56.2%, phosphate; 58.2%, calcium; 67.1%, albumin; and 91.1%, catheter. Estimated patient life years gained with improved compliance with guidelines was highest for albumin (3.670) and catheter use (2.331) but still substantial for the other four targets (ranging from 551 to 1.258). The total of patient years gained if 100% of patients have all six practices brought within target reaches 7.516 years. A conservative estimate of 50% of patients within all targets still yields an improvement of survival of 3.958 patient years.
This analysis suggests large opportunities to improve HD patient care in Belgium. The avoidance of HD catheters, with the use of AV fistulas whenever possible, should be given a high priority. Admittedly, these calculations assume causality or partial causality that has not been definitively proven. Still, if causality is only partial, the results emphasize that the improvement of patient care through adherence to targets of clinical guidelines might be substantial and all Belgian nephrologists and staff members of dialysis units should carefully pursue every potential effort.
多个组织已发布了血液透析患者护理的临床实践指南。然而,在比利时,改善甚至达到完全遵循指南的程度能在多大程度上提高血液透析患者的生存率尚不清楚。
利用透析结果和实践模式研究(DOPPS)第二阶段的数据,计算未达到六个关键实践指标(Kt/V≥1.2、血红蛋白≥11g/dl、磷酸盐1.1 - 1.5mmol/l、钙2.1 - 2.4mmol/l、白蛋白≥40g/l以及中心静脉导管使用率≤10%)的血液透析患者比例,以及未达到这些指标相关的死亡相对风险。然后分别估算并汇总遵循这六个指标可能获得的生命年数。
未达指标的患者百分比分别为:Kt/V为30.3%;血红蛋白为33.6%;磷酸盐为56.2%;钙为58.2%;白蛋白为67.1%;导管为91.1%。随着对指南依从性的提高,估算患者获得的生命年数白蛋白最高(3.670),导管使用次之(2.331),但其他四个指标也相当可观(范围从551到1.258)。如果100%的患者所有六个指标都达标,总共可获得7.516个患者生命年。保守估计50%的患者所有指标达标仍可使生存率提高3.958个患者生命年。
该分析表明在比利时改善血液透析患者护理有很大机会。应高度优先考虑避免使用血液透析导管,尽可能使用动静脉内瘘。诚然,这些计算假设了尚未得到明确证实的因果关系或部分因果关系。即便因果关系只是部分存在,结果也强调通过遵循临床指南指标改善患者护理可能意义重大,所有比利时肾病学家和透析单位工作人员都应认真尽一切可能努力。